Financière de Tubize

Financière de Tubize is an investment holding company that primarily operates within the biopharmaceuticals sector. It holds a significant stake in UCB, a global biotechnology firm renowned for developing treatments for neurological and immunological conditions. UCB generates most of its revenue from the United States, with additional sales in Europe and other international markets. The company's product lineup predominantly features neurology-related therapies, followed by immunology treatments. UCB's strategic approach emphasizes the application of scientific advancements and expertise in genetics, biomarkers, and human biology to drive innovation and growth in its market offerings.